The brokerage sees Conviction estimates to increase in 2017 and argues the future impact of "The Walking Dead" is not understood correctly.
The analysts project AOCF of $36 million once the show completes its ninth season. Therefore, the analysts reiterated their Buy rating with a target price of $89 on the company's shares.
The analysts pointed out the following bear case factors:
- "The Walking Dead" has crossed its peak.
- No replacement show exists with comparable metrics.
- Revenue and AOCF will struggle for growth.
The brokerage pointed to the first-quarter advertising revenue to support its argument that revenue and AOCF would grow. Ad revenue rose 1 percent despite the year-ago quarter had two more episodes of "Better Call Saul" and the the 90-minute "Walking Dead" season finale.
"Assuming $2 million in advertising per BCS episode and 36 national spots for TWD at $400,000 each implies that on a comparable basis advertising revenue grew 8 percent, while TWD A18-49 viewers (Live +3) were down 11 percent," the analysts told clients in a research note.
The brokerage does not believe the bears' argument that profitability would drop and that the terminal value would be impaired once the show ends its run. CLSA sees loss of ad revenue as the only factor to impact AOCF on a year-over-year basis. Secondly, the series is an in-house show. Therefore, there is no change in the margin level from all revenue streams that is predicted at ~49 percent.
The analysts added, "In the remaining years of its run, costs should continue to grow but advertising is likely to fade, which means lower margin and smaller impact on AOCF."
AMC was up 1.18 percent at time of writing, seen trading at $51.12.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.